Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 32 % of short-term debt in 2025; threshold 65 %.
-
Shrinking team NBB
FTE fell two years in a row, from 3 to 1.
Financials
Financial year 2025
ERC BELGIUM from Gembloux, company number BE0895963165, closed financial year 2025 with a result of € 574,631 after tax. For that financial year ERC BELGIUM recorded revenue of € 1.5 million and equity of € 2.5 million. Compared with financial year 2024, the result moved from € -215,987 to € 574,631. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.
€ 2.5 million
▲ 29% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 574,631
▲ still € 215,987 loss in 2024
Profit after tax over the fiscal year.
€ 98
▼ 60% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 161,759.
People and assets in 2025
1
▼ 1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 95,301
▼ 50% vs 2024
€ 95,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 1.5 million
Loans from banks and other lenders, long and short.
€ 3.8 million
▲ 2% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 104,017
▼ 53% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | - | - | € 1,544,529 | |
| Gross margin | € -938,543 | € 5,599,312 | € 882,909 | € 1,778,958 | ▲ 101% |
| Profit after taxes | € 102,039 | € -561,294 | € -215,987 | € 574,631 | ▲ € 790,618 |
| Equity | € 2,741,409 | € 2,180,115 | € 1,964,129 | € 2,538,760 | ▲ 29% |
| Total debts | € 10,039,351 | € 9,018,280 | € 8,601,358 | € 9,048,631 | ▲ 5% |
| Cash | € 303,598 | € 13,171 | € 246 | € 98 | ▼ 60% |
| Retained profit | € 364,409 | € -196,885 | € -412,871 | € 161,759 | ▲ € 574,631 |
| Bank debt | € 1,557,387 | € 1,504,530 | € 1,466,913 | € 1,466,901 | |
| Balance sheet total | € 12,780,760 | € 11,198,395 | € 10,565,486 | € 11,587,390 | ▲ 10% |
| Employees (FTE) | 3 | 3 | 2 | 1 | ▼ 1 |
Key figures of ERC BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ERC BELGIUM?
What happened at ERC BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Vittorio LAURIENTE stepped down as director. NBB
- Joseph ELLIOT stepped down as director. NBB
- Bernard ALLIAUME stepped down as director. NBB
- Constantin JANSSEN DE LA BOESSIERE-THIENNES stepped down as director. NBB
- Mohamad KASSAS stepped down as director. NBB
- Apostolos STATHOPOULOS stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 574,631. Source: NBB ↗
- Agamemnon VARONOS stepped down as director. NBB
In short
From € 102,039 profit in 2022 to € 574,631 profit in 2025.
Paid € 1,602 in corporate taxes since 2022.
Best year ever: 2025, with € 574,631 profit.
On average € 1.8 million of value added per employee in 2025.
Management
It owns 100% of ERC PHARMA, 80% of ERC THE NETHERLANDS and 80% of Erc USA itself.
Directors
According to the 2025 annual accounts
Vittorio LAURIENTE
Director
Also active at: SAMBRELEASE, FONDS DE CAPITAL A RISQUE 2020, LAURI INVEST, 6K venture capital, SAMBRINVEST SPIN-OFF/SPIN-OUT
since 2024 · until 2029
Joseph ELLIOT
Vice-chairman of the board
since 2024 · until 2029
Metin BAKAR
Director
since 2025 · until 2026
Apostolos STATHOPOULOS
Managing director
since 2023 · until 2028
Agamemnon VARONOS
Director
since 2025 · until 2026
Bernard ALLIAUME
Vice-chairman of the board
since 2024 · until 2029
Constantin JANSSEN DE LA BOESSIERE-THIENNES
Director
Also active at: Mobilière et Immobilière du Centre, FEJ
since 2024 · until 2029
since 2024 · until 2029
Establishments
Establishment units
Physical locations of this company
Rue Jean Sonet,Isnes 10
5032 Gembloux
Grotstraat 14
1020 Brussel
Active since 29 November 2018
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
DIGITALOCEAN-ASN - DigitalOcean, LLC, US
DNS
GoDaddy DNS
Domain
Domain
erc-immunotherapy.com
Registered
2016-05-18
Registrar
GoDaddy.com, LLC
Expires
2026-05-18
Website info
Features
Security
Details
- Company number
- 0895.963.165
- VAT number
- BE 0895.963.165
- Registered office
- Rue Jean Sonet,Isnes 10, 5032 Gembloux
- Names & denominations
- ERC BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 25 February 2008
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- erc-immunotherapy.com
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van overige farmaceutische producten